Vanguard Fiduciary Trust
DNA icon

Vanguard Fiduciary Trust’s Ginkgo Bioworks DNA Stock Holding History

Vanguard Fiduciary Trust’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.1M Buy
312,573
+37,834
+14% +$316K ﹤0.01% 2447
2026
Q1 		$1.68M Buy
+274,739
New +$2.29M ﹤0.01% 2654

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Vanguard Fiduciary Trust's DNA Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Ginkgo Bioworks (DNA) stake by 14% in Q2 2026, buying an estimated $316K and bringing the position to 312,573 shares worth $3.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2447.

Vanguard Fiduciary Trust first reported a position in DNA in Q1 2026 and has held it in 2 quarters since. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Vanguard Fiduciary Trust held 312,573 shares of Ginkgo Bioworks worth $3.1M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 37,834 Ginkgo Bioworks shares in Q2 2026, an estimated $316K.
  • Ginkgo Bioworks made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2447 holding.
  • Vanguard Fiduciary Trust first reported a position in Ginkgo Bioworks in Q1 2026 and has held it in 2 quarters since.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.